Candidiasis: From cutaneous to systemic, new perspectives of potential targets and therapeutic strategies.
Lu H, Hong T, Jiang Y, Whiteway M, Zhang S.
Adv Drug Deliv Rev. 2023 Aug;199:114960. doi: 10.1016/j.addr.2023.114960. Epub 2023 Jun 10.
PMID:37307922
Candida albicans accelerates atherosclerosis by activating intestinal hypoxia-inducible factor2alpha signaling.
Wang X, Zhou S, Hu X, Ye C, Nie Q, Wang K, Yan S, Lin J, Xu F, Li M, Wu Q, Sun L, Liu B, Zhang Y, Yun C, Wang X, Liu H, Yin WB, Zhao D, Hang J, Zhang S, Jiang C, Pang Y.
Cell Host Microbe. 2024 Jun 12;32(6):964-979.e7. doi: 10.1016/j.chom.2024.04.017. Epub 2024 May 15.
PMID:38754418
Prenatal maternal infection promotes tissue-specific immunity and inflammation in offspring.
Lim AI, McFadden T, Link VM, Han SJ, Karlsson RM, Stacy A, Farley TK, Lima-Junior DS, Harrison OJ, Desai JV, Lionakis MS, Shih HY, Cameron HA, Belkaid Y.
Science. 2021 Aug 27;373(6558):eabf3002. doi: 10.1126/science.abf3002.
PMID:34446580
The gut, the bad and the harmless: Candida albicans as a commensal and opportunistic pathogen in the intestine.
Zhai B, Ola M, Rolling T, Tosini NL, Joshowitz S, Littmann ER, Amoretti LA, Fontana E, Wright RJ, Miranda E, Veelken CA, Morjaria SM, Peled JU, van den Brink MRM, Babady NE, Butler G, Taur Y, Hohl TM.
Nat Med. 2020 Jan;26(1):59-64. doi: 10.1038/s41591-019-0709-7. Epub 2020 Jan 6.
PMID:31907459
Esophageal, gastric, and intestinal candidiasis.
Trier JS, Bjorkman DJ.
Am J Med. 1984 Oct 30;77(4D):39-43.
PMID:6548606
Candida albicans infection and intestinal immunity.
Tong Y, Tang J.
Microbiol Res. 2017 May;198:27-35. doi: 10.1016/j.micres.2017.02.002. Epub 2017 Feb 13.